Ovid Therapeutics Inc.

OVIDNASDAQHealthcareBiotechnology

$2.37- (-)1Y +51.92%

As of Oct 22, 2026 close

Market cap: $174.75M
P/E (TTM): -
Forward P/E: -
Dividend yield: -
52-week range: $1.18$3.11
Volume (live): -
Avg. volume (3M): 1.86M

Ovid Therapeutics Inc. (OVID) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Ovid Therapeutics Inc. stock.

Analyst Consensus Rating

Investment consensus from 10 professional research analysts

Consensus Rating

Buy

Based on 10 unique analysts

(11 total ratings in last 90 days)

High Confidence∞:1 Buy/Sell

Average Price Target

$6.57

+177.22% upside

Loading chart...

Strong Sell

Sell

Hold

Buy

Strong Buy

Latest OVID Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Date	Analyst	Firm	Action	Rating	Price Target
Oct 15, 2026	Rudy Li	Wolfe Research	Initiates	Buy	$5.00
Oct 9, 2026	Imogen Mansfield	Cantor Fitzgerald	Initiates	Buy	-
Oct 8, 2026	Laura Chico	Wedbush	Maintains	Buy	$7.00
Oct 5, 2026	Unknown Analyst	Guggenheim	Initiates	Buy	$7.00
Sep 11, 2026	Ram Selvaraju	HC Wainwright	Reiterates	Buy	$4.00 → $5.00 +1.00 (+25.0%)
Sep 3, 2026	Boobalan Pachaiyappan	Roth MKM	Maintains	Buy	$8.00
Aug 14, 2026	Francois Brisebois	LifeSci Capital	Reiterates	Buy	$5.00
Aug 14, 2026	Laura Chico	Wedbush	Maintains	Buy	$7.00
Aug 14, 2026	Kostas Biliouris	Oppenheimer	Reiterates	Buy	$9.00
Aug 13, 2026	Myles Minter	William Blair	Maintains	Buy	-
Aug 13, 2026	Ritu Baral	TD Cowen	Maintains	Buy	-

Rudy Li

Wolfe Research

BuyInitiates

$5.00

Oct 15

Imogen Mansfield

Cantor Fitzgerald

BuyInitiates

Oct 9

Laura Chico

Wedbush

BuyMaintains

$7.00

Oct 8

Unknown Analyst

Guggenheim

BuyInitiates

$7.00

Oct 5

Ram Selvaraju

HC Wainwright

BuyReiterates

$4.00 → $5.00

Sep 11

Boobalan Pachaiyappan

Roth MKM

BuyMaintains

$8.00

Sep 3

Francois Brisebois

LifeSci Capital

BuyReiterates

$5.00

Aug 14

Laura Chico

Wedbush

BuyMaintains

$7.00

Aug 14

Kostas Biliouris

Oppenheimer

BuyReiterates

$9.00

Aug 14

Myles Minter

William Blair

BuyMaintains

Aug 13

Ritu Baral

TD Cowen

BuyMaintains

Aug 13

Source: Professional analyst ratings and price targets from the last 90 days. Data as of Oct 15, 2026. Data sources and methodology

Frequently Asked Questions

What is the analyst consensus rating for OVID?

The analyst consensus rating for OVID is Buy, based on the latest ratings from 10 analysts over the last 90 days.

What is the average price target for OVID?

The average 12-month price target for OVID is $6.57, representing an upside of 177.2% from the Oct 22, 2026 close of $2.37.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.